Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
about
The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in miceThe Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine TuberculosisRNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication.Brucella melitensis VjbR and C12-HSL regulons: contributions of the N-dodecanoyl homoserine lactone signaling molecule and LuxR homologue VjbR to gene expression.A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosisEvaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent miceMechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challengeBrucellosis: the case for live, attenuated vaccines.Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidatesLipopolysaccharide-Deficient Brucella Variants Arise Spontaneously during Infection.Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheresAerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.What have we learned from brucellosis in the mouse model?Meta-Analysis and Advancement of Brucellosis Vaccinology.VirB12 is a serological marker of Brucella infection in experimental and natural hosts.Deletion of the Small RNA Chaperone Protein Hfq down Regulates Genes Related to Virulence and Confers Protection against Wild-Type Brucella Challenge in MiceIn vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and exportThe Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehiclePyruvate kinase is necessary for Brucella abortus full virulence in BALB/c mouse.Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.Disruption of the BMEI0066 gene attenuates the virulence of Brucella melitensis and decreases its stress tolerance.Characterization of Brucella abortus mutant strain Δ22915, a potential vaccine candidate.Confronting the barriers to develop novel vaccines against brucellosis.Internal affairs: investigating the Brucella intracellular lifestyle.Considerations for Infectious Disease Research Studies Using Animals.Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent.Brucella melitensis VirB12 recombinant protein is a potential marker for serodiagnosis of human brucellosis.Protection Provided by an Encapsulated Live Attenuated ΔabcBA Strain of Brucella ovis against Experimental Challenge in a Murine Model.Brucella Rough Mutant Induce Macrophage Death via Activating IRE1α Pathway of Endoplasmic Reticulum Stress by Enhanced T4SS Secretion.Cold shock protein A plays an important role in the stress adaptation and virulence of Brucella melitensis.Pathological changes and bacteriological assessments in the urinary tract of pregnant goats experimentally infected with Brucella melitensis.
P2860
Q24635244-CF8481F3-A7F5-469E-9FAA-48461FA20122Q26740410-42286265-FD00-497E-8878-C1141A149411Q33354944-8F3513F9-89E6-469D-9631-D8478A638988Q33597099-F6928D0B-0D6F-4C01-83B3-8F02890E4072Q33716740-E8EA9054-86B0-4EAD-A3C1-1BB50C710FEEQ33755285-40398CC0-5F9D-4C6F-AC14-771D46778DBDQ33826026-DF27B3A9-44DE-472F-972D-4A1F8B2A0450Q33899699-9346A108-C6A5-422C-8960-9CAA978CEABDQ34199069-7B725AFA-C8E4-4DDA-973D-8E17E05D6C56Q34459329-59A0F6A7-0DAF-42BA-943C-D933A7A71A0BQ34612868-66B341A1-7F73-4E95-9B11-FC82E92A795FQ34756533-2D2354CE-F4BB-4263-96DF-0BE90E7496CAQ35155281-80B38B3E-EC81-46FF-AAAD-3D8FC6F73CEDQ35191851-07EA9E33-D741-43AC-9738-3AC8E35D48F6Q35273029-22278895-DFE5-44BF-8484-B492D541F88EQ35739119-BA8203AF-EDAA-42AD-90A4-3341B6AF4777Q35954584-5F67700F-B580-477D-813B-665727DBA7B0Q36097216-EF217C5F-CCB0-4C65-938B-7A63CDF0769EQ36136716-B13A79F5-03AB-4F22-84A8-5D3A583269C1Q36192841-D3443B29-0906-4350-B5AC-CB04CD4C7F98Q36452324-0D418F3A-E1B1-4F70-84FF-480E5B29ABA9Q36480175-B5035200-BB34-423F-AA38-38F807E24526Q36606794-7B27A54D-45CB-4E99-A460-4BF5A2797221Q36710777-9ABBD3FA-C44A-4480-B1D7-1989A52E8A40Q36747173-0F9665B6-EADC-487D-B3D1-076C2ECF7067Q36755736-47B08A80-1E41-437E-AE3B-024EC43CFAACQ37075414-B77CC626-66D9-49A7-BCC1-0BF44F416338Q37209653-8514DE0F-BCB8-4675-B968-2E1EB3BD9F57Q37270179-5167B1EE-68B2-4F4F-978D-EE847D4C8770Q37332823-49F7A116-DADD-416B-928E-210AF9DE106FQ37737947-7B29FC01-8417-4455-B10F-EAD60D231518Q37932521-712B79A7-DF36-4BC0-A9EC-19E05667F877Q37988968-9D520622-0A9F-45D2-8F1D-A5E972D74228Q38701962-88D62AAC-F3F6-4979-B62D-E644D761E575Q40067441-F1FD521B-52C9-4513-82AE-7AE47F7DE5DCQ40310905-502243F8-4DC4-49E1-8D68-A8A716BE4CBAQ41839463-D2034264-CFB4-45DA-9CD0-97309192E4D3Q41986737-245AEA0E-D5F3-4BD3-B490-3B824AF1D665Q48013466-69971221-2156-441D-8FB4-7A4440C92A50Q55447712-CB148321-4D08-442F-8E37-7E9C0297089D
P2860
Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@ast
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@en
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@nl
type
label
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@ast
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@en
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@nl
prefLabel
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@ast
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@en
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@nl
P2860
P356
P1476
Evaluation of protection affor ...... s of clearance in BALB/c mice.
@en
P2093
M M Kahl-McDonagh
P2860
P304
P356
10.1128/IAI.01787-05
P407
P577
2006-07-01T00:00:00Z